Skip to main content
Nature Portfolio logoLink to Nature Portfolio
. 2023 Jul 4;2(8):793. doi: 10.1038/s44161-023-00310-1

Publisher Correction: Systems immunology-based drug repurposing framework to target inflammation in atherosclerosis

Letizia Amadori 1,2,#, Claudia Calcagno 3,4,#, Dawn M Fernandez 5, Simon Koplev 6, Nicolas Fernandez 6, Ravneet Kaur 1, Pauline Mury 5, Nayaab S Khan 5, Swathy Sajja 1, Roza Shamailova 1, Yannick Cyr 1, Minji Jeon 6, Christopher A Hill 5, Peik Sean Chong 2, Sonum Naidu 3,4, Ken Sakurai 3,4, Adam Ali Ghotbi 3,4, Raphael Soler 3,4, Natalia Eberhardt 1, Adeeb Rahman 2,7, Peter Faries 8, Kathryn J Moore 1, Zahi A Fayad 3,4, Avi Ma’ayan 6, Chiara Giannarelli 1,5,9,
PMCID: PMC11041730  PMID: 38666036

Correction to: Nature Cardiovascular Research 10.1038/s44161-023-00278-y. Published online 8 June 2023.

In the version of this article initially published, a protein (pMAPKAPK2) was misspelled in Fig. 1 and Extended Data Fig. 7; a colored box for “AKT” was missing from the second column of regulators in Fig. 5a; Extended Data Fig. 2f was missing a header above the color key; and typographical errors (extraneous citations to refs. 1, 3 and 5) were present in the “Analysis of RNA-seq data from saracatinib-treated tissue” section of Methods. In addition, the Reporting Summary and the legends for Supplementary Figs. 5 and 8 were outdated versions. The errors have been corrected in the HTML and PDF versions of the article.


Articles from Nature Cardiovascular Research are provided here courtesy of Nature Publishing Group

RESOURCES